261 related articles for article (PubMed ID: 27496117)
1. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Provenzale D; Gupta S; Ahnen DJ; Bray T; Cannon JA; Cooper G; David DS; Early DS; Erwin D; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Hampel H; Ismail MK; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Mayer RJ; Ness RM; Regenbogen SE; Samadder NJ; Shike M; Steinbach G; Weinberg D; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2016 Aug; 14(8):1010-30. PubMed ID: 27496117
[TBL] [Abstract][Full Text] [Related]
2. Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registry.
Alric H; Coffin E; Lekhal C; Benusiglio PR; Dhooge M; Colas C; Caron O; Cusin V; Becq A; Perez Cuadrado Robles E; Leenhardt R; Perkins G; Buecher B; Bellanger J; Rahmi G; Malka D; Laurent-Puig P; Chaussade S; Benamouzig R; Parc Y; Cellier C; Perrod G
Dig Liver Dis; 2024 Apr; 56(4):672-678. PubMed ID: 37758611
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.
Boland PM; Yurgelun MB; Boland CR
CA Cancer J Clin; 2018 May; 68(3):217-231. PubMed ID: 29485237
[TBL] [Abstract][Full Text] [Related]
4. The "scope" of colorectal cancer screening in Lynch syndrome: is there an optimal interval?
Biller LH; Ng K
J Natl Cancer Inst; 2023 Jul; 115(7):775-777. PubMed ID: 37140568
[No Abstract] [Full Text] [Related]
5. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
Crosbie EJ; Ryan NAJ; Arends MJ; Bosse T; Burn J; Cornes JM; Crawford R; Eccles D; Frayling IM; Ghaem-Maghami S; Hampel H; Kauff ND; Kitchener HC; Kitson SJ; Manchanda R; McMahon RFT; Monahan KJ; Menon U; Møller P; Möslein G; Rosenthal A; Sasieni P; Seif MW; Singh N; Skarrott P; Snowsill TM; Steele R; Tischkowitz M; ; Evans DG
Genet Med; 2019 Oct; 21(10):2390-2400. PubMed ID: 30918358
[TBL] [Abstract][Full Text] [Related]
6. The search for unaffected individuals with Lynch syndrome: do the ends justify the means?
Hampel H; de la Chapelle A
Cancer Prev Res (Phila); 2011 Jan; 4(1):1-5. PubMed ID: 21205737
[TBL] [Abstract][Full Text] [Related]
7. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Cragun D; DeBate RD; Vadaparampil ST; Baldwin J; Hampel H; Pal T
Genet Med; 2014 Oct; 16(10):773-82. PubMed ID: 24651603
[TBL] [Abstract][Full Text] [Related]
8. Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-Analysis.
Power RF; Doherty DE; Parker I; Gallagher DJ; Lowery MA; Cadoo KA
JCO Precis Oncol; 2024 Jan; 8():e2300196. PubMed ID: 38207227
[TBL] [Abstract][Full Text] [Related]
9. How do we approach the goal of identifying everybody with Lynch syndrome?
Hampel H; de la Chapelle A
Fam Cancer; 2013 Jun; 12(2):313-7. PubMed ID: 23568035
[No Abstract] [Full Text] [Related]
10. Beyond familial risk: deriving risk-adapted starting ages of screening among people with a family history of colorectal cancer.
Chen X; Heisser T; Cardoso R; Hibbert J; Hoffmeister M; Brenner H
Cancer Commun (Lond); 2023 Dec; 43(12):1377-1380. PubMed ID: 37874634
[No Abstract] [Full Text] [Related]
11. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
[TBL] [Abstract][Full Text] [Related]
12. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
13. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
[TBL] [Abstract][Full Text] [Related]
14. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
[TBL] [Abstract][Full Text] [Related]
16. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial.
Metcalfe KA; Dennis CL; Poll A; Armel S; Demsky R; Carlsson L; Nanda S; Kiss A; Narod SA
Genet Med; 2017 Mar; 19(3):330-336. PubMed ID: 27584910
[TBL] [Abstract][Full Text] [Related]
17. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
Guo Y; Warren Andersen S; Shu XO; Michailidou K; Bolla MK; Wang Q; Garcia-Closas M; Milne RL; Schmidt MK; Chang-Claude J; Dunning A; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bogdanova NV; Bonanni B; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Brüning T; Burwinkel B; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; Jenkins M; John EM; Johnson N; Jones ME; Kabisch M; Kibriya M; Knight JA; Koppert LB; Kosma VM; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Luben R; Lubinski J; Malone KE; Mannermaa A; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perez JI; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Seynaeve C; Shah M; Shrubsole MJ; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Whittemore AS; Winqvist R; Zhao H; Zhao S; Hall P; Simard J; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
PLoS Med; 2016 Aug; 13(8):e1002105. PubMed ID: 27551723
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.
Haraldsdottir S; Rafnar T; Frankel WL; Einarsdottir S; Sigurdsson A; Hampel H; Snaebjornsson P; Masson G; Weng D; Arngrimsson R; Kehr B; Yilmaz A; Haraldsson S; Sulem P; Stefansson T; Shields PG; Sigurdsson F; Bekaii-Saab T; Moller PH; Steinarsdottir M; Alexiusdottir K; Hitchins M; Pritchard CC; de la Chapelle A; Jonasson JG; Goldberg RM; Stefansson K
Nat Commun; 2017 May; 8():14755. PubMed ID: 28466842
[TBL] [Abstract][Full Text] [Related]
20. Update on Hereditary Colorectal Cancer.
DA Silva FC; Wernhoff P; Dominguez-Barrera C; Dominguez-Valentin M
Anticancer Res; 2016 Sep; 36(9):4399-405. PubMed ID: 27630275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
